Supplementary Table 1 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379147

2023-01-01

Abstract:Supplementary Table 1 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

What problem does this paper attempt to address?

Supplementary Table 2 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379144

2023-01-01

Abstract:Supplementary Table 2 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer
Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379141

2023-01-01

Abstract:Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer
Tgfbr1 Haplotypes and Risk of Non-Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming Yu,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.can-08-4602

IF: 11.2

2009-01-01

Cancer Research

Abstract:Transforming growth factor beta (TGF-beta) receptors are centrally involved in TGF-beta-mediated cell growth and differentiation and are frequently inactivated in non-small-cell lung cancer (NSCLC). Constitutively decreased type I TGF-beta receptor (TGFBR1) expression is emerging as a novel tumor-predisposing phenotype. The association of TGFBR1 haplotypes with risk for NSCLC has not yet been studied. We tested the hypothesis that single-nucleotide polymorphisms (SNP) and/or TGFBR1 haplotypes are associated with risk of NSCLC. We genotyped six TGFBR1 haplotype-tagging SNPs (htSNP) by PCR-RFLP assays and one htSNP by PCR-single-strand conformation polymorphism assay in two case-control studies. Case-control study 1 included 102 NSCLC patients and 104 healthy controls from Suzhou. Case-control study 2 included 131 patients with NSCLC and 133 healthy controls from Wuxi. Individuals included in both case-control studies were Han Chinese. Haplotypes were reconstructed according to the genotyping data and linkage disequilibrium status of these seven htSNPs. None of the htSNP was associated with NSCLC risk in either study. However, a four-marker CTGC haplotype was significantly more common among controls than among cases in both studies (P = 0.014 and P = 0.010, respectively), indicating that this haplotype is associated with decreased NSCLC risk {adjusted odds ratio [OR], 0.09 [95% confidence interval (95% CI), 0.01-0.61] and 0.11 [95% CI, 0.02-0.59], respectively}. Combined analysis of both studies shows a strong association of this four-marker haplotype with decreased NSCLC risk (adjusted OR, 0.11; 95% CI, 0.03-0.39). This is the first evidence of an association between a TGFBR1 haplotype and risk for NSCLC.
SNP Rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Yu Wang,Rongna Ma,Ben Liu,Jinyu Kong,Hongyan Lin,Xiao Yu,Ruoyang Wang,Lei Li,Ming Gao,Baosen Zhou,Man Mohan,Herbert Yu,Zhaoyuan Hou,Hongbin Shen,Biyun Qian

DOI: https://doi.org/10.1038/s41388-020-1278-4

2019-01-01

Abstract:Genome-wide association studies (GWAS) have identified numerous genetic variants that are associated with lung cancer risk, but the biological mechanisms underlying these associations remain largely unknown. Here we investigated the functional relevance of a genetic region in 6q22.2 which was identified to be associated with lung cancer risk in our previous GWAS. We performed linkage disequilibrium (LD) analysis and bioinformatic prediction to screen functional SNPs linked to a tagSNP in 6q22.2 loci, followed by two case-control studies and a meta-analysis with 4403 cases and 5336 controls to identify if these functional SNPs were associated with lung cancer risk. A novel SNP rs17079281 in the DCBLD1 promoter was identified to be associated with lung cancer risk in Chinese populations. Compared with those with C allele, patients with T allele had lower risk of adenocarcinoma (adjusted OR = 0.86; 95% CI: 0.80–0.92), but not squamous cell carcinoma (adjusted OR = 0.99; 95% CI: 0.91–1.10), and patients with the C/T or T/T genotype had lower levels of DCBLD1 expression than those with C/C genotype in lung adenocarcinoma tissues. We performed functional assays to characterize its biological relevance. The results showed that the T allele of rs17079281 had higher binding affinity to transcription factor YY1 than the C allele, which suppressed DCBLD1 expression. DCBLD1 behaved like an oncogene, promoting tumor growth by influencing cell cycle progression. These findings suggest that the functional variant rs17079281C>T decreased lung adenocarcinoma risk by creating an YY1-binding site to suppress DCBLD1 expression, which may serve as a biomarker for assessing lung cancer susceptibility.
Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Pengyuan Liu,Haris G. Vikis,Yan Lu,Yian Wang,Ann G. Schwartz,Susan M. Pinney,Ping Yang,Mariza de Andrade,Adi Gazdar,Colette Gaba,Diptasri Mandal,Juwon Lee,Elena Kupert,Daniela Seminara,John Minna,Joan E. Bailey-Wilson,Christopher I. Amos,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/1055-9965.22435836.v1

2023-01-01

Abstract:Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer
Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Yan Liu,Pengyuan Liu,Weidong Wen,Michael A. James,Yian Wang,Joan E. Bailey-Wilson,Christopher I. Amos,Susan M. Pinney,Ping Yang,Mariza de Andrade,Gloria M. Petersen,Jonathan S. Wiest,Pamela R. Fain,Ann G. Schwartz,Adi Gazdar,Colette Gaba,Henry Rothschild,Diptasri Mandal,Elena Kupert,Juwon Lee,Daniela Seminara,John Minna,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/0008-5472.22382063

2023-01-01

Abstract:Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Relationship between genetic susceptibility of non-small ceil lung cancer and the TGF-βRI gene

Lei Hong,Shi-ying Zheng,Jun Zhao

2008-01-01

Abstract:Objective To investigate whether the transforming growth factor-beta receptor type I (TGF-βRI) gene is associated with genetic predisposition of primary non-small cell lung cancer (NSCLC). Methods The entire coding region of TGF-βRI and flanking intron sequences from 53 NSCLC tissues were examined for alterations using SSCP and direct sequencing. Results No somatic point muta-tions other than two silent mutations and a polymorphism were found in the TGF-βRI gene. The two silent mutations located at codon 544 (AAT to AAC) and codon 406 (TrA to CTA) ,respectively,and the poly-morphism was at 24 th base of intron7 (G to A). Interestingly,we found that the subjects with homozygous genotype A/A displayed more than threefold increased risk of developing NSCLC than the common wild genotype G/G. Conclusion As the first report,this study showed that TGF-βRI gene is not a frequent site of spontaneous mutational inactivation while the detected polymorphism could be a susceptibility allele that predisposes to carcinogenesis of NSCLC. Key words: TGF-βRI; NSCLC; Mutation; Polymorphism
Supplementary Table 5 and 6 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461762.v1

2023-01-01

Abstract:Table 5:Correlation between FGFR fusion and expression Table 6: Clinicopathologic Characteristics of 734 Patients with NSCLC in Survival analysis
A Haplotype of Tgfbr1 is Predominantly Found in Non-Small Cell Lung Cancer Patients Displaying Tgfbr1 Allelic-Specific Expression

Jinxia Sun,Zhe Lei,Reng-Yun Liu,Yufeng Lu,Zhixiang Zhuang,Xiefang Jiang,Qian,Zeyi Liu,Jun Zhao,Hong-Tao Zhang

DOI: https://doi.org/10.3892/or.2011.1135

2011-01-01

Oncology Reports

Abstract:Non-small cell lung cancer (NSCLC) accounts for ~85% of all cases of lung cancer and TGF-ß refractoriness is very common in NSCLC cells. Constitutively decreased TGFBR1 expression, probably leading to TGF-ß resistance in tumors, is emerging as a novel tumor-predisposing phenotype. However, the precise genetic/epigenetic mechanisms underlying the role of TGFBR1 in NSCLC carcinogenesis are still largely unknown. In the present study, we performed the SNaPshot method to quantify allelic-specific expression (ASE) of two chosen SNPs that are located in the 3' untranslated region (3' UTR) of the TGFBR1 gene. We selected seven tagging SNPs (tSNPs) of TGFBR1 to assess the relationship between ASE of TGFBR1 and tSNP-reconstructed haplotypes in NSCLC tumors. ASE of TGFBR1 was detected in 21.1% of NSCLC tumors. One tagging SNP (rs7040869) of TGFBR1 in the 5' flanking region was found to be significantly associated with TGFBR1 ASE in NSCLC tumors (P=0.03). A 2-tSNP AT haplotype reconstructed with tSNP rs7040869 and rs4743325, in linkage disequilibrium with each other, was strongly associated with NSCLC cases displaying ASE (P=0.01). In conclusion, our results shed light on the high frequency of TGFBR1 ASE phenotype in NSCLC tumors, which is associated with the 2-tSNP haplotype of the TGFBR1 gene. Although this suggests an important role of the TGFBR1 locus in the etiology of NSCLC, additional studies at the germline level and in various ethnic populations are warranted.
Supplementary Table 4 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461768

2023-01-01

Abstract:Independent predictors of FGFR1/3 fusions in 1328 patients with NSCLCs in multivariate analysis
No association between TGFBR1*6A and lung cancer.

Weiming You,Zeyi Liu,Jun Zhao,Mingfeng Zheng,Shi-Ying Zheng,Xia Liu,Hong-Tao Zhang

DOI: https://doi.org/10.1097/JTO.0b013e318070ccd7

IF: 20.121

2007-01-01

Journal of Thoracic Oncology

Abstract:TGFBR1*6A, a functionally polymorphic allele in the transforming growth factor [beta] receptor 1 gene (TGFBR1), has been hypothesized to increase risk of various cancers. However, little has been documented about connection of this variant with lung cancer.In an attempt to explore whether the TGFBR1*6A is associated with lung cancer, we performed genotyping followed by sequencing in 252 patients with lung cancer and 250 healthy controls.The frequency for the heterozygote 9A/6A is 13.9% in cases compared with 12.4% in controls, and the odds ratio is 1.14 (95% confidence interval: 0.68-1.91), which is not statistically significant (p = 0.62), suggesting that TGFBR1*6A could not be a cancer susceptibility factor for Chinese patients with lung cancer.We have no evidence to support the hypothesis that TGFBR1*6A is associated with lung cancer.
Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Xia Pu,Jack A. Roth,Michelle A.T. Hildebrandt,Yuanqing Ye,Hua Wei,John D. Minna,Scott M. Lippman,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22399995.v1

2023-01-01

Abstract:Supplementary Table 1-3 PDF file - 162K, Supplementary tables 1 and 2 include effect of selected SNPs on overall survival or recurrence in early stage NSCLC patients; Supplementary table 3 includes all the SNPs selected in the analysis
Mutational Analysis of the Transforming Growth Factor Β Receptor Type I Gene in Primary Non-Small Cell Lung Cancer

HT Zhang,QY Fei,F Chen,QY Qi,W Zou,JC Wang,RM Zhang,SH Tao,XF Chen,ZW Luo

DOI: https://doi.org/10.1016/s0169-5002(03)00121-1

IF: 6.081

2003-01-01

Lung Cancer

Abstract:Transforming growth factor-beta receptor-dependent signals are critical for cell growth and differentiation and are often disrupted during tumorigenesis. The entire coding region of TGFbetaRI and flanking intron sequences from 53 primary non-small cell lung cancer (NSCLC) tissues were examined for alterations using SSCP and direct sequencing. No somatic point mutations other than two silent mutations and a polymorphism were found in the TGFbetaRI gene. The two silent mutations located at codon 344 (AAT to AAC) and codon 406 (TTA to CTA), respectively, and the polymorphism was at the 24th base of intron 7 (G to A). To investigate whether the presence of this polymorphism is associated with NSCLC, we determined its allele distribution in all the 53 carcinomas and 89 normal controls. Interestingly, we found that the subjects with homozygous genotype A/A displayed more than 3-fold increased risk of developing NSCLC than the common wild genotype G/G. As the first report, the present study showed that TGFbetaRI gene is not a frequent site of spontaneous mutational inactivation while the detected polymorphism is frequent in the pathogenesis of NSCLC.
Supplementary Table 5 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461759.v1

2023-01-01

Abstract:PDF file - 56KB, Correlation between FGFR fusion and expression.
Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

Yanbo Teng,Yanjun Ding,Mingming Zhang,Xinren Chen,Xizi Wang,Hang Yu,Chonghui Liu,Hongchao Lv,Ruijie Zhang

DOI: https://doi.org/10.1016/j.jtbi.2018.08.007

2018-11-07

Abstract:Lung cancer is the leading cause of cancer-related death worldwide. Most lung cancer is non-small cell lung cancer (NSCLC), in which malignant cells form in the lung epithelium. Mutations in multiple genes and environmental factors both contribute to NSCLC, and although some NSCLC susceptibility genes have been characterized, the pathogenesis of this disease remains unclear. To identify genes conferring NSCLC risk and determine their associated pathological mechanism, we combined genome-wide haplotype associated analysis with gene prioritization using 224,677 SNPs in 37 NSCLC cell lines and 116 unrelated European individuals. Five candidate genes were identified: ESR1, TGFBR1, INSR, CDH3, and MAP3K5. All of these have previously been implicated in NSCLC, with the exception of CDH3, which can therefore be considered a novel indicator of NSCLC risk. Functional annotation confirmed the relationship between these five genes and NSCLC. Our findings are indicative of the underlying pathological mechanisms of NSCLC and provide information to support future directions in diagnosing and treating NSCLC.
Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Xia Pu,Yuanqing Ye,Margaret R. Spitz,Liang Wang,Jian Gu,Scott M. Lippman,Michelle A.T. Hildebrandt,Waun Ki Hong,John D. Minna,Jack A. Roth,Ping Yang,Xifeng Wu

DOI: https://doi.org/10.1158/1078-0432.22446162

2023-01-01

Abstract:PDF file - 83k, Supplementary Table 1: Inflammation-related pathways selected in this study Supplementary Table 2: Effect of selected SNPs on survival in adenocarcinoma female patients Supplementary Table 3: Effect of selected SNPs on survival duration in patients with late-stage lung cancer Supplementary Table 4: Effect of selected SNPs on survival duration in patients by gender
Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

Chen Wu,Zhibin Hu,Dianke Yu,Liming Huang,Guangfu Jin,Jie Liang,Huan Guo,Wen Tan,Mingfeng Zhang,Ji Qian,Daru Lu,Tangchun Wu,Dongxin Lin,Hongbing Shen

DOI: https://doi.org/10.1158/0008-5472.22377476.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations
Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461774.v1

2023-01-01

Abstract:Clinicopathologic Characteristics in NSCLC Patients with FGFR, ALK, RET and ROS1 fusions
TGFβ1 Gene Polymorphisms with the Risk of Radiation Pneumonitis in Non-Small Cell Lung Cancer in Different Ethnic Study.

X. Niu,S. Lu,H. Li,Y. Liu,Z. Chen,D. Zhou,M. Kan,Z. Li,Y. Yu,C. LV

DOI: https://doi.org/10.1200/jco.2011.29.15_suppl.10606

IF: 45.3

2011-01-01

Journal of Clinical Oncology

Abstract:10606 Background: To investigate whether non–small-cell lung cancer (NSCLC) patients in Chinese with risk of radiation pneumonitis (RP) (grade≥3) by radiotherapy display reliable single nucleotide polymorphisms (SNPs) marker(s) located in transforming growth factor 1 (TGFβ1) gene. Methods: DNA was isolated from blood samples obtained from NSCLC patients (n=167) treated with deﬁnitive radiotherapy alone (n=125) or concurrent chemoradiation (n=42). Eight SNPs of the TGFβ1 gene (rs1800469, rs1800471, rs1982073, rs4803455, rs11466345, rs12983047, rs10417924, and rs10980942) were genotyped by direct DNA sequencing method. Kaplan-Meier cumulative probability was used to assess the risk of grade≥3 RP and Cox proportional hazards analysis to evaluate the effect of TGFβ1 genotypes on such risk. Results: There were 125 men and 42 women in the study with median age of 58 years. 53 (31.7%) patients developed grade 2 RP, 46 (27.5%) developed grade≥3 RP, respectively, based on CTCAEv3.0. SNP rs1982073 with RP risk in Caucasians was failed to validate to associate with the risk of grade≥3 RP in Chinese NSCLC patients. Multivariate analysis found AG/GG genotypes of novel TGFβ1 rs11466345 to be associated with a statistically signiﬁcantly higher risk of RP grades≥3 (HR=2.295; 95% CI, 1.101 to 4.783; P=0.027), compared with the AA genotype, after adjustment for age, smoking status, and dosimetric parameters. Conclusions: Our results showed that AG/GG genotypes of novel TGFβ1 rs11466345 were associated with higher risk of RP in Chinese NSCLC patients treated with radiotherapy. Further studies are warranted to confirm these findings in different ethnic populations.

Supplementary Table 1 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 2 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Tgfbr1 Haplotypes and Risk of Non-Small-Cell Lung Cancer

SNP Rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Relationship between genetic susceptibility of non-small ceil lung cancer and the TGF-βRI gene

Supplementary Table 5 and 6 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

A Haplotype of Tgfbr1 is Predominantly Found in Non-Small Cell Lung Cancer Patients Displaying Tgfbr1 Allelic-Specific Expression

Supplementary Table 4 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

No association between TGFBR1*6A and lung cancer.

Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Mutational Analysis of the Transforming Growth Factor Β Receptor Type I Gene in Primary Non-Small Cell Lung Cancer

Supplementary Table 5 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

TGFβ1 Gene Polymorphisms with the Risk of Radiation Pneumonitis in Non-Small Cell Lung Cancer in Different Ethnic Study.

Supplementary Table 1 from &lt;i&gt;TGFBR1&lt;/i&gt; Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 2 from &lt;i&gt;TGFBR1&lt;/i&gt; Haplotypes and Risk of Non–Small-Cell Lung Cancer